BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34612767)

  • 1. CHI3L1 (Chitinase 3 Like 1) upregulation is associated with macrophage signatures in esophageal cancer.
    Huang J; Gu Z; Xu Y; Jiang L; Zhu W; Wang W
    Bioengineered; 2021 Dec; 12(1):7882-7892. PubMed ID: 34612767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
    Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
    World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 4. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
    Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
    Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

  • 6. Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
    Zhao T; Zeng J; Xu Y; Su Z; Chong Y; Ling T; Xu H; Shi H; Zhu M; Mo Q; Huang X; Li Y; Zhang X; Ni H; You Q
    Theranostics; 2022; 12(16):6989-7008. PubMed ID: 36276655
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases.
    Zhao H; Huang M; Jiang L
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
    Chen Y; Zhang S; Wang Q; Zhang X
    J Hematol Oncol; 2017 Feb; 10(1):36. PubMed ID: 28143526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53.
    Liu K; Jin M; Ye S; Yan S
    J Clin Lab Anal; 2020 Jan; 34(1):e23026. PubMed ID: 31536166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitinase 3-Like 1 Contributes to Food Allergy via M2 Macrophage Polarization.
    Kim EG; Kim MN; Hong JY; Lee JW; Kim SY; Kim KW; Lee CG; Elias JA; Song TW; Sohn MH
    Allergy Asthma Immunol Res; 2020 Nov; 12(6):1012-1028. PubMed ID: 32935492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration.
    Xu N; Bo Q; Shao R; Liang J; Zhai Y; Yang S; Wang F; Sun X
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4596-4605. PubMed ID: 31675076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-24 Modulates Staphylococcus aureus-Induced Macrophage Polarization by Suppressing CHI3L1.
    Jingjing Z; Nan Z; Wei W; Qinghe G; Weijuan W; Peng W; Xiangpeng W
    Inflammation; 2017 Jun; 40(3):995-1005. PubMed ID: 28303416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization.
    Kim M; Chang JY; Lee DW; Kim YR; Son DJ; Yun J; Jung YS; Lee DH; Han S; Hong JT
    Mol Immunol; 2023 Apr; 156():98-110. PubMed ID: 36921490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chi3l1 regulates APAP-induced liver injury by promoting macrophage infiltration.
    Wang Y; Zhong M; Wang W; Li YH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4996-5003. PubMed ID: 31210337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2a Macrophage-Secreted CHI3L1 Promotes Extracellular Matrix Metabolic Imbalances
    Li L; Wei K; Ding Y; Ahati P; Xu H; Fang H; Wang H
    Front Immunol; 2021; 12():666361. PubMed ID: 34168643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer.
    Yu JE; Yeo IJ; Han SB; Yun J; Kim B; Yong YJ; Lim YS; Kim TH; Son DJ; Hong JT
    Exp Mol Med; 2024 Feb; 56(1):1-18. PubMed ID: 38177294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
    Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
    Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.